Antithrombotic Treatment (Argatroban vs. Heparin) in Coronary Angioplasty in Angina Pectoris: Effects on Inflammatory, Hemostatic, and Endothelium-Derived Parameters
- 15 May 2000
- journal article
- Published by Elsevier in Thrombosis Research
- Vol. 98 (4) , 269-279
- https://doi.org/10.1016/s0049-3848(99)00237-6
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Relationship of C-Reactive Protein to Risk of Cardiovascular Disease in the ElderlyArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Fibrin(ogen) and von Willebrand Factor Deposition Are Associated With Intimal Thickening After Balloon Angioplasty of the Rabbit Carotid ArteryArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Leukocyte activation with platelet adhesion after coronary angioplasty: A mechanism for recurrent disease?Journal of the American College of Cardiology, 1996
- Coronary Angioplasty in Patients with Unstable Angina, with Special Reference to Preceding Treatment with Antithrombin III and HeparinClinical and Applied Thrombosis/hemostasis, 1996
- Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six monthsThe Lancet, 1994
- Endogenous tissue-type plasminogen activator and risk of myocardial infarctionThe Lancet, 1993
- Clinical Application of the Synthetic Thrombin Inhibitor, Argatroban (MD-805)Seminars in Thrombosis and Hemostasis, 1992
- Detection of intracoronary fibrin degradation after coronary balloon angioplastyThe American Journal of Cardiology, 1991
- Importance of antithrombin therapy during coronary angioplastyJournal of the American College of Cardiology, 1991
- The role of platelets, thrombin and hyperplasia in restenosis after coronary angioplastyJournal of the American College of Cardiology, 1991